OnabotulinumtoxinA

Details

Files
Generic Name:
OnabotulinumtoxinA
Project Status:
Complete
Therapeutic Area:
Migraine
Manufacturer:
Allergan Inc.
Call for patient/clinician input open:
Brand Name:
Botox
Project Line:
Reimbursement Review
Project Number:
SR0345-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Migraine, chronic
Recommendation Type:
Do not list
Final Recommendation:

Request for Resubmission: Eligible (Decision Date: June 5, 2018)